| (EUR) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 310.24M | — |
| Operating expense | — | — |
| Net income | 27.93M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CJH.F returned -45.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -18.2% |
| 1 year | -45.8% |
| 5 years | -89.8% |
| All-time high | €45.51 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in CJH.F would be worth today ›No. CanSino Biologics Inc. has not paid a dividend in the past 12 months.
CanSino Biologics Inc. is part of the Healthcare sector.
CanSino Biologics Inc. has a market cap of 755.95M EUR, based on the latest quote.
CanSino Biologics Inc. is scheduled to report earnings on Aug 27, 2026.
